Electroporation Instruments Market to Grow Significantly with Increased Use in Drug Delivery
Electroporation Instruments Market |
The electroporation instruments
market has witnessed significant growth in recent years owing to the rising
adoption of electroporation technology in diverse drug delivery applications
such as gene therapy and cancer treatment. Electroporation instruments employ
electrical pulses to reversibly permeabilize the cell membrane, allowing
otherwise impermeable molecules to enter the cells. The growing utility of
electroporation for the delivery of chemotherapeutics, proteins, DNA, and RNA
molecules has boosted the uptake of electroporation instruments across
pharmaceutical and biotechnology companies.
The global electroporation
instruments market is estimated to be valued at US$ 279.26 billion in 2024 and is expected to exhibit a CAGR of 12% over the forecast period
from 2024 to 2031.
Key Takeaways
Key players operating in the electroporation instruments market are Arduino,
Adafruit, SparkFun, Seeed Studio, Microchip, NXP Semiconductors,
STMicroelectronics, Texas Instruments, Cypress Semiconductor, Silicon Labs,
Renesas Electronics, Infineon Technologies, Maxim Integrated, ON Semiconductor,
Microchip Technology, Semtech, Analog Devices, ROHM Semiconductor, FTDI Chip,
Intel. Electroporation
Instruments Market Trends finds widespread application in biotechnology
research areas ranging from prokaryotic to eukaryotic cells. Some of the key
opportunities in the market include development of next-generation instruments
with improved features and increasing adoption in immunotherapy. Major players
are focused on expanding their geographical footprint to capitalize on high growth
markets such as Asia Pacific and Middle East & Africa.
Market Drivers and Restraints
Rising incidences of cancer is a key factor driving the demand for effective
drug delivery methods like electroporation. According to WHO, cancer burden is
expected to grow to 27.5 million new cancer cases and 16.3 million cancer
deaths by 2040. Electroporation provides a non-viral mode for targeted cancer
treatment through localized drug delivery. Growing R&D investments by
pharmaceutical firms in cell-based therapies is another key market driver. High
costs of electroporation instruments and need for specialized training to
efficiently operate such technologically advanced systems are major restraints
to market growth. Reluctance to replace conventional transfection methods also
hinders adoption.
Segment
Analysis
The electroporation instruments
market is segmented based on technology, product type, end user and
application. The technology segment includes electron pulse and heat pulse
electroporation instruments. Electron pulse electroporation instruments
dominates the market due to its wide usage in transfection, microbial
electroporation, and non-thermal permeabilization for introducing exogenous
molecules into cells and tissues. The product type segment includes electroporation
generators, electroporation cuvettes/cuvettes, electroporation gene/RNA
pulsers/ systems and other consumables. Electroporation generators dominates
the market as it facilitates the process across various applications. End user
segment includes pharmaceutical and biotech companies, academic and research
institutes, and other end users. Pharmaceutical and biotech companies dominates
the end user segment due to their extensive research and manufacturing
activities. The application segment covers transfection, microbial
electroporation, and other applications. The transfection segment dominates the
application segment as it helps facilitate the process of deliberately
introducing nucleic acids into cells using physical methods.
Global Analysis
Regionally, North America holds
maximum share in the electroporation instruments market due to the presence of
leading pharmaceutical and research companies in the region. Europe region is
the second fastest growing market due to increased funding by governments and
organizations for research. The Asia Pacific region is expected to grow at the
highest CAGR during the forecast period due to increasing outsourcing of
clinical research to emerging Asian countries like China and India by
pharmaceutical companies, growth of the pharmaceutical industry, rising
awareness about advanced therapeutic procedures, and improving healthcare
infrastructure. Key players in the market are focusing on new product launches
and expanding their regional presence through acquisitions and collaborations
to strengthen their market position.
Gets
More Insights on, Electroporation
Instruments Market
About Author:
Money Singh is a seasoned content writer with over four years of
experience in the market research sector. Her expertise spans various
industries, including food and beverages, biotechnology, chemical and
materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)
Comments
Post a Comment